share_log

10-Q: Q2 2024 Earnings Report

10-Q: Q2 2024 Earnings Report

10-Q:2024财年二季报
美股SEC公告 ·  2024/08/15 04:51

Moomoo AI 已提取核心信息

Safety Shot Inc. reported Q2 2024 revenue of $710,240, up significantly from $23,305 in Q2 2023, driven by the launch of its Safety Shot Dietary Supplement in December 2023. Gross profit was $205,712 compared to a loss of $4,270 in the prior year period. Cost of sales increased to $504,528 reflecting startup costs associated with the product launch.Operating expenses surged to $8.6 million from $1.7 million year-over-year, primarily due to increased marketing expenses of $2.6 million, legal and professional fees of $1.9 million, and stock-based compensation of $3.0 million. The company employed a comprehensive marketing approach including digital and retail activations, social media, and broadcast events. Research and development costs were $119,911.The company ended the quarter with $3.2 million in cash. Management noted ongoing litigation matters including lawsuits from warrant holders seeking damages. While expressing confidence in vigorously defending these claims, the company acknowledged the need to potentially raise additional capital to execute its business plan, though warrant exercises and marketable securities holdings provide some financial flexibility.
Safety Shot Inc. reported Q2 2024 revenue of $710,240, up significantly from $23,305 in Q2 2023, driven by the launch of its Safety Shot Dietary Supplement in December 2023. Gross profit was $205,712 compared to a loss of $4,270 in the prior year period. Cost of sales increased to $504,528 reflecting startup costs associated with the product launch.Operating expenses surged to $8.6 million from $1.7 million year-over-year, primarily due to increased marketing expenses of $2.6 million, legal and professional fees of $1.9 million, and stock-based compensation of $3.0 million. The company employed a comprehensive marketing approach including digital and retail activations, social media, and broadcast events. Research and development costs were $119,911.The company ended the quarter with $3.2 million in cash. Management noted ongoing litigation matters including lawsuits from warrant holders seeking damages. While expressing confidence in vigorously defending these claims, the company acknowledged the need to potentially raise additional capital to execute its business plan, though warrant exercises and marketable securities holdings provide some financial flexibility.
Safety Shot Inc.报告了2024年第二季度营业收入为710,240美元,较2023年第二季度的23,305美元大幅增长,这是由于其于2023年12月推出的Safety Shot膳食补充剂所驱动。毛利润为205,712美元,而去年同期则亏损4,270美元。销售成本增加到了504,528美元,反映出与产品推出相关的启动成本。营业费用从去年的170万美元大幅攀升至860万美元,主要是由于营销费用增加了260万美元,法律及专业费用为190万美元,以及基于股票的补偿为300万美元。公司采取了综合营销方式,包括数字和零售激活、社交媒体及广播活动。研究与开发费用为119,911美元。公司在季度末现金余额为320万美元。管理层提到正在进行的诉讼事项,包括寻求赔偿的权证持有人的诉讼。尽管表示对积极应对这些索赔的信恳智能,但公司承认需要可能筹集额外资本来执行其业务计划,尽管权证行使和可交易证券持有提供了一定的财务灵活性。
Safety Shot Inc.报告了2024年第二季度营业收入为710,240美元,较2023年第二季度的23,305美元大幅增长,这是由于其于2023年12月推出的Safety Shot膳食补充剂所驱动。毛利润为205,712美元,而去年同期则亏损4,270美元。销售成本增加到了504,528美元,反映出与产品推出相关的启动成本。营业费用从去年的170万美元大幅攀升至860万美元,主要是由于营销费用增加了260万美元,法律及专业费用为190万美元,以及基于股票的补偿为300万美元。公司采取了综合营销方式,包括数字和零售激活、社交媒体及广播活动。研究与开发费用为119,911美元。公司在季度末现金余额为320万美元。管理层提到正在进行的诉讼事项,包括寻求赔偿的权证持有人的诉讼。尽管表示对积极应对这些索赔的信恳智能,但公司承认需要可能筹集额外资本来执行其业务计划,尽管权证行使和可交易证券持有提供了一定的财务灵活性。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息